Related Experiment Video

Updated: Jun 29, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

Etiology and prognosis of acute liver failure in children

Anil Dhawan1

  • 1Paediatric Liver Centre, King's College London School of Medicine, King's College Hospital, London, United Kingdom. anil.dhawan@kcl.ac.uk

Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
|October 1, 2008
PubMed

Insights

Acute liver failure in children has varied causes globally, unlike in adults. Prognostic criteria for survival without liver transplantation are lacking in pediatric cases, necessitating careful genetic evaluation.

Area of Science:

  • Pediatric Hepatology
  • Clinical Pediatrics
  • Gastroenterology

Background:

  • Acute liver failure (ALF) in children presents distinct etiological patterns compared to adults.
  • Metabolic disorders are frequent causes in Europe and North America, while Hepatitis A is prevalent in Asia and South America.
  • Encephalopathy is often a late indicator and not a prerequisite for diagnosing pediatric ALF.

Purpose of the Study:

  • To highlight the unique etiological factors of acute liver failure in pediatric populations.
  • To underscore the diagnostic and prognostic challenges in pediatric ALF.
  • To emphasize the importance of genetic screening prior to liver transplantation in children.

Main Methods:

  • Comparative analysis of etiological data across different geographic regions.
  • Review of diagnostic criteria for pediatric acute liver failure.
  • Evaluation of prognostic indicators and pre-transplant assessments.

Main Results:

  • Etiology of pediatric ALF varies significantly by region, with metabolic conditions and Hepatitis A being key drivers.
  • Reliable prognostic criteria for predicting survival without liver transplantation are currently unavailable for children.
  • Genetic multisystem disorders require exclusion before considering pediatric liver transplantation.

Conclusions:

  • Understanding regional etiological differences is crucial for managing pediatric acute liver failure.
  • The absence of clear prognostic markers necessitates a cautious approach to liver transplantation in children.
  • Thorough genetic evaluation is a critical step in the management pathway for pediatric patients with acute liver failure.

More Related Videos

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube

Published on: April 28, 2020

Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration05:37

Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration

Published on: May 31, 2018

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Acute Pancreatitis I: Introduction01:25

Acute Pancreatitis I: Introduction

Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...